Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.63 USD | +1.22% | -2.73% | -5.29% |
May. 17 | HC Wainwright Adjusts Kala Pharmaceuticals Price Target to $18 From $21, Maintains Buy Rating | MT |
Apr. 02 | HC Wainwright Trims KALA BIO's Price Target to $21 From $22, Keeps Buy Rating | MT |
- Stock Market
- Equities
- KALA Stock
- News KALA BIO, Inc.
- Press Releases